2022 American Transplant Congress Archives - Page 27 of 190

Early Clinical Complications Following HLA-Incompatible Living Donor Kidney Transplantation

J. D. Motter¹, K. Jackson¹, A. Massie¹, J. Garonzik-Wang², D. Segev¹
Early Clinical Experience With Alvr109, A Partially Hla-matched Sars-cov-2 Specific T-cell Therapy, In Immunocompromised Patients With Covid-19

G. Haidar¹, J. Jacobs², K. Hughes², K. McCormick², A. Naqvi², M. Agha², T. Bogdanovich², B. Johnson², J. Kozar², E. Lendermon², C. Marino², A. Raptis², F. Silveira², W. Marshall³, M. Miller³, E. Atillasoy³, J. Mellors²
Early Clinical Experience With Nirmatrelvir/ritonavir For Treatment Of Covid-19 In Solid Organ Transplant Recipients

D. Salerno¹, D. Jennings², N. Lange³, D. Kovac¹, T. Shertel¹, J. Chen⁴, J. Hedvat⁵, J. Scheffert¹, R. S. Brown⁶, M. Pereira⁷
Early Detection of Acute Rejection by Urine QSant is Not Confounded by Post-Transplant Time

C. Baan¹, S. Ghosh², J. Verhoeven¹, D. Hesselink¹, K. Boer¹, M. Sarwal²
Early Evaluation Of The Impact Of Change In UNet Organ Refusal Code Reasons On Us Transplant Center Organ Offers

S. Noreen¹, C. Martinez¹, S. Mohan², K. McCharen¹, A. Placona¹, R. Patzer³
Early Experience Of 48-hour Normothermic Machine Perfusion In Human Kidneys Applying Urine Recirculation

F. Messner¹, S. Gasteiger¹, M. Pühringer-Sturmayr¹, A. Soleiman¹, D. Öfner¹, S. Schneeberger¹, A. Weissenbacher²
Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients

S. Mouawad¹, C. Shoemaker², J. Geyston³, A. Nishio Lucar³
Early Experience with OmniGraf® Biomarker Surveillance in Kidney Transplant Patients in the First-Year Post-Transplant and Beyond

V. Paramasivam¹, W. Ally², B. Sivakumar³, B. Greco¹, M. Germain¹
Early Experience with Varicella Vaccination in Pediatric Heart Transplant Recipients

A. Dipchand, M. Seifert-Hansen
Early Experiences with Developing the Techniques of Pure Laparoscopic Explant Hepatectomy without Fragmentation in Living Donor Liver Transplantation

S. Hong¹, C. Kim¹, S. Lee², S. Suh², S. Hong¹, E. Han¹, Y. Choi³, N. Yi², K. Lee³, K. Suh¹
Early Il-33 Action on Myeloid Cells is Critical In Resistance to Systemic Candida Albicans Infection

H. Cho¹, S. Park¹, B. Kwon², H. Park¹, Y. Kim³, J. Lee⁴, J. Park⁴, K. Park⁴, K. Yoo⁴
Early Impact of the Mission Act on Utilization of Veterans Affairs Transplant Centers

J. C. Walker¹, C. Roumie², I. D. Feurer³, R. Forbes⁴
Early Kidney Transplantation Irrespective of Donor Profile Offers Survival Benefit in Recipients Older Than 70 Years

A. Mujkanovic¹, T. Jarmi², C. B. Taner¹, K. P. Croome¹, S. A. Mao¹
Early Mortality After Liver Transplant is Associated with Pre-Transplant Alterations in Monocyte Phenotype and Gene Expression

L. Jin¹, A. Lemenze², G. Panayotova¹, S. Simonishvili¹, Y. Qin¹, T. Ayorinde¹, G. Prakash¹, L. J. Minze³, F. Paterno¹, L. Brown¹, A. Amin¹, X. C. Li³, R. Ghobrial³, J. V. Guarrera¹, K. E. Lunsford¹
Early Outcomes for Liver Transplant with Thoracoabdominal Normothermic Regional Perfusion for Donation After Circulatory Death: A Multi-Center Experience

A. L. Brubaker¹, A. Lee¹, B. Jackson¹, J. Berumen¹, J. R. Parekh¹, K. L. Mekeel¹, A. R. Gupta², J. M. Gardner², T. Chaly³, A. K. Mathur⁴, C. Jadlowiec⁴, K. Reddy⁴, R. Nunez⁴, J. Bellingham⁵, E. Thomas⁶, J. R. Wellen⁷, M. Kearns¹, V. Pretorius¹, G. T. Schnickel¹
Early Outcomes of Kidney Transplant Recipients from Donors with Severe Sars-cov-2 Pneumonia

M. Rosenzweig, M. Finotti, A. Gupta, S. Lee, N. Onaca, G. J. McKenna, J. Bayer, H. Fernandez, R. Ruiz, E. Martinez, A. Yango, T. Sam, C. Spak, B. Fischbach, G. Testa, A. Wall
Early Outcomes of Single Dose Eculizumab for Abo-Incompatible Living Donor Renal Transplantation

K. Heagler, M. Campara, P. Di Cocco, S. Gaitonde, I. Tang, J. Almario Alvarez, M. Spaggiari, J. Benken, C. S. Muran, B. Valdepenas, D. Pierce, I. Tzvetanov, E. Benedetti
Early Outcomes Since Implementation of New Kidney Allocation System

K. Shah, F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann
Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: A Retrospective Case Series

R. Seneriz¹, A. Mattiazzi¹, G. Guerra¹, T. Harrington², M. Velasquez³
Early Retrieval of the Right Kidney for Combined Heart and Kidney Transplantation is Feasible and Reduces Costs

H. Podder¹, R. McMillan², S. Yi², M. Hobeika³, D. Nguyen², E. Graviss², R. Whitehead², R. J. Knight⁴, M. Ghobrial², A. O. Gaber²
Early Tacrolimus Exposure is Associated with BK-Viremia in Kidney Transplant Recipients

S. Meziyerh, A. L. van Rijn, D. van der Helm, P. J. van der Boog, T. van Gelder, A. C. Kroes, J. W. de Fijter, D. J. Moes, J. I. Rotmans, M. C. Feltkamp, A. P. de Vries
Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

A. Hutchins¹, M. Leick², M. Keck², J. S. McMullen²
Early versus Late Ureteral Stent Removal in Pediatric Kidney Transplant Recipients

A. McGrath¹, L. Maestretti¹, S. Samreth¹, K. Sheth², P. Grimm², A. Chaudhuri², A. Gallo²
Early vs. Late Heparin Administration After Declaration of Death in DCD Donors Does Not Impact Short Term Outcomes in Kidney Transplantation

A. M. Hawxby, R. Ketcham, R. Squires, J. P. Orlowski, H. Solomon, C. Hostetler
EBV+ PTLD Tumor MicroRNAs Detected in Circulating Extracellular Vesicles Are Decreased in Pediatric Transplant Recipients with EBV+ PTLD

A. Sen¹, J. Enriquez¹, M. Rao¹, M. Glass¹, Y. Balachandran¹, S. Syed¹, C. Twist¹, K. Weinberg¹, S. D. Boyd¹, D. Bernstein¹, A. Trickey¹, D. Gratzinger¹, B. Tan¹, M. G. Lapasaran¹, M. A. Robien², M. Brown³, B. Armstrong⁴, M. Sever⁴, D. Desai⁵, G. Mazariegos⁶, C. Chin⁷, T. Fishbein⁸, R. S. Venick⁹, A. Tekin¹⁰, H. Zimmermann¹¹, R. U. Trappe¹², C. O. Esquivel¹, O. M. Martinez¹, S. M. Krams¹
Effect Of A Fourth Covid-19 Vaccine Dose On Omicron Variant Neutralization In Solid Organ Transplant Recipients

A. Karaba, A. Abedon, J. Alejo, C. X. Qin, D. Warren, J. Ruff, T. Aytenfisu, T. S. Johnston, O. Akinde, A. Pekosz, S. Klein, A. Cox, D. Segev, A. Tobian, W. Werbel
Effect of Abdominal Aortic Calcification on Renal Function After Liver Transplantation

R. Ide, M. Ohira, R. Arata, K. Imaoka, K. Ono, T. Mochizuki, N. Tsukiyama, A. Seidakhmetov, H. Yamane, K. Sato, Y. Imaoka, H. Mashima, D. Marlen, R. Nakano, M. Hashimoto, N. Tanimine, S. Kuroda, H. Tahara, K. Ide, T. Kobayashi, Y. Tanaka, H. Ohdan
Effect of Anti Thymocyte Globulin Induction Therapy in Kidney Transplantation Network Meta-Analysis Using Recent Data

S. Hwang, J. Song, K. Kim, S. Lee
Effect of CD8+ Cell Depletion in Treg Mediated Skin Graft Survival

R. Steiner¹, A. M. Weijler¹, M. Muckenhuber², J. Sprent³, T. Wekerle⁴, N. Pilat¹
Effect of Covid-19 Diagnosis on Organ Donation and Transplantation

L. Baetje¹, A. Cheng¹, S. Sander², L. Markham², M. Ott², J. Finn², A. Wee³, K. Dyer⁴, A. Atluri¹, D. Jahandar¹, M. Moncure⁴
Effect of Covid-19 Vaccination on Markers of Rejection in Heart Transplant Recipients

Z. Pieters¹, E. Bruno¹, S. Kim¹, S. De Sirkar¹, M. Thomas¹, S. B. Sharmin², M. Liebo¹, A. Heroux¹, N. Clark¹, G. Reid¹, S. Uprichard², M. Yu¹
Effect of Dual Inhibition of DPP4 and SGLT2 on Tacrolimus-Induced Diabetes Mellitus and Nephrotoxicity in Rat Model

E. Ko, Y. Shin, C. Seung, S. Lim, B. Chung, C. Yang
Effect of Immunosuppression Withdrawal After Graft Failure on Re-Kidney Transplantation Outcomes

J. Ahn¹, S. Sandal², S. Bae¹, D. Segev¹, M. McAdams-DeMarco¹
Effect of Micafungin Bridging on Prevention of Invasive Candidiasis Post Lung Transplantation

C. Baladad¹, M. Converse¹, K. DeSear¹, S. Karimi¹, E. Rubido¹, G. El Helou², T. Pasley¹
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

J. Mitchell¹, T. P. Chiang¹, J. Alejo¹, A. Chang¹, A. Abedon¹, R. Avery¹, A. Tobian¹, A. Massie¹, M. Levan¹, D. Warren¹, J. Garonzik-Wang², D. Segev¹, W. Werbel¹
Effect of Prophylactic Treatment of Osteoporosis on the Progression of Bone Mineral Density and Fractures in Lung Transplant Recipients – A Five-Year, Single-Center Experience

P. Singh¹, A. Ross², J. Mejia¹, T. E. Pesavento¹, S. Meng¹
Effect of Sars-CoV-2 Delta Variant on Post-Vaccination COVID-19 Infection in Solid Organ Transplant Recipients

E. Tuttle¹, J. Moon², T. J. Grazia³, T. Sam⁴, S. Mathai³
Effect of Schisandra Sphenanthera Extract on Pharmacokinetics of Tacrolimus in Pediatric Renal Transplant Recipients

J. Jiang¹, H. Zhang¹, X. Su¹, S. Wu¹, Y. Chen², W. Chen², J. Li², C. Wu², L. Yang², L. Liu², C. Wang²
Effect Of The SRTR COVID-19 3-month Carve-out On Program-specific Transplant Outcome Evaluations

J. Miller¹, G. R. Lyden¹, D. Zaun¹, B. Kasiske², R. Hirose³, A. Israni², J. Snyder¹
Effectiveness and Limitations of PK Analysis in Optimization of Immunosuppressive Therapy for Kidney Transplantation

M. Okumura, K. Ishiyama, S. Ashimine, Y. Miwa, K. Iwasaki, T. Kobayashi
Effectiveness of a Targeted Media Campaign on Engagement and Interest in Living Donation

L. A. Davis¹, A. Livingston², A. Waterman³
Effector T Cells Potentiate Treg Migration to Allografts

H. Baydoun, M. Fathallah, A. Pena, B. Robinson, G. Camirand
Effects of Pre-Lung Transplantation Pulmonary Rehabilitation on Functional Capacity and Quality of Life

R. M. AlGhofaily
Effects of Race, Previous CoV2 Exposure and the Length and Type of Maintenance Immunosuppression on Protective Immunity to COVID19 Vaccine in Solid Organ Transplant Recipients

A. Choudhary¹, M. Lerman², S. Khan², J. Hunt², A. Nikaein³, D. Calianese¹, E. Kalu², D. K. Jaijyan⁴, W. Honnen¹, A. Pinter¹
Efficacy and Safety of a Delayed Graft Function Protocol in Kidney Transplant Recipients

V. Vu¹, S. Bhayana², H. Sweiss¹, N. Castro¹, R. Hall¹, J. Nelson¹
Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients

G. Urias¹, J. Benken¹, A. Lichvar², D. Pierce¹, L. Andrews¹, K. Dalton³, A. Datta¹, H. Nishioka¹, E. Benedetti¹, S. Benken¹
Efficacy and Safety of Delayed, Low-Dose Valganciclovir in High-Risk Cytomegalovirus Liver Transplant Recipients

S. Anders¹, A. Freeman¹, L. Hutchinson¹, U. Kaszubski¹, M. Janusek¹, A. Hooter², D. Raymond², C. Nguyen²
Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients

W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han
Efficacy and Safety of PCSK-9 Inhibitor, Evolocumab for Lipid Management in Kidney Transplant Recipients

J. Pandav¹, R. Saranu¹, S. Muhsin¹, N. Murakami¹, S. Gabardi¹, K. Safa², A. Chandraker¹
Efficacy of a Multispecialty, Multidisciplinary Strategy to Improve the Level of Awareness and Control of Cardiovascular Risk Factors After Liver Transplantation

G. Crespo, L. Sastre, R. García, C. Viñals, A. J. Amor, G. Yago, A. Hervas, L. Sánchez, J. Trabal, J. Molero, L. Escude, G. Pagano, M. Blasco, R. Gilabert, P. Ruiz, J. Colmenero, M. Navasa, E. Ortega
Electrospun Poly-ε-Caprolactone Scaffolds Incorporating Decellularized Extracellular Matrix for Suturable Tissue Engineered Small Vascular Graft

A. Han¹, S. Min¹, E. Cho¹, H. Woo¹, A. Cho¹, J. Ha¹, Y. Ju², S. Min¹
Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period is Associated with an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients

D. Wojciechowski¹, A. Patel², S. Anand³, J. Klein⁴, A. Paramesh⁵, P. Sood⁶, G. Shekhtman⁷, N. Agrawal⁷, M. Fei⁷, K. Qu⁷, D. C. Brennan⁸
Eliminating Hepatitis C Positive Status from Kidney Donor Profile Index (KDPI) Calculations Results in Improved Transplant Rates and Outcomes in an Elderly Veteran Population

R. Lopez-Soler¹, A. Thorndyke¹, C. Trotter¹, A. Abadier², M. Samra¹
Emphysematous Cystitis in a Lung Transplant Recipient with BK Viremia

D. Razia, J. Klein, H. Mohamed, A. Arjuna
En-Bloc Kidney Transplantation in Children Over a 33-year Period in USA – A Comparative Study

P. Gogalniceanu¹, I. D. Kostakis², P. Chandak³, G. Papadakis⁴, J. Stojanovic⁵, F. Calder⁴, I. Loukopoulos⁴, N. Kessaris⁴
End-to-Side Splenic to Hepatic Artery Reconstruction in Liver Transplant: A Case Series

N. Baker, L. Aviles-Ovalle, T. Baker, J. Campsen, R. Kim, G. Rofaiel
Engineered Adaptable Human Endothelial Cells Enable Durable Engraftment of Subcutaneously Transplanted Islets

R. Craig-Schapiro, G. Li, S. Rafii
Engineered IL-2 Plus Calcineurin Inhibitor Synergistically Expands Regulatory T Cells Transduced with Engineered IL-2 Receptor and Facilitates Establishment of Transplantation Tolerance

T. Hirai¹, P. Lin², T. L Ramos², K. Garcia³, R. S Negrin²
Enhanced Delivery of Nanomedicine to Human Kidney During Ex Vivo Perfusion

C. Albert¹, L. Bracaglia¹, A. Koide², J. R. DiRito¹, T. Lysyy¹, E. Christopher¹, J. Grundler¹, J. T. Langford¹, D. Haakinson¹, J. S. Pober¹, W. M. Saltzman¹, S. Koide², G. Tietjen¹
Enhanced Histological Yield and Actionable Findings When Biopsy is Guided by Donor-Derived Cell-Free DNA (dd-cfDNA)

M. R. Weir¹, D. Mandelbrot², J. S. Bromberg¹, S. Mehta³, E. Poggio⁴, E. Huang⁵, G. Shekhtman⁶, N. Agrawal⁷, W. Tian⁸, M. Cooper⁹
Enhancing Early Nerve Regeneration from Reconstruction of a Segmental Nerve Injury with Polyethylene Glycol

A. Bernal¹, C. Hinshaw¹, J. Hinshaw¹, C. Yang², S. Margaux¹, W. Zhang¹, J. Nuelle¹, C. Sabbag¹, G. Bittner², J. Shores³, E. Weitzel¹, J. Alderete¹
Epidemiology of Post Transplant Diabetes Mellitus

S. Al Rasbi, I. Salmi
Equity in Access to Deceased Donor Transplant for Candidates on the Heart Waitlist

K. Bradbrook¹, A. Robinson¹, R. Goff¹, D. Stewart²
Equivalence of Pediatric Paper and Electronic-Based Patient-Reported Outcome Measures: Findings from a Systematic Review

S. Kortbeek¹, A. Pawaria², V. L. Ng¹
Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?

A. Kwong, A. Mannalithara, W. Kim
ESRD is Increasing Faster After Living Kidney Donation Than it Does in the Unselected US Population: A New Risk Metric?

R. W. Steiner
Establishing a Framework for Long-Term Follow-Up: A Survey of Perspectives and Preferences of Living Kidney Donors

S. K. Singh¹, N. Caton², O. Johnston², C. S. Hanson³, A. Dominello³, K. Yetzer⁴, D. Chang², A. Tong³, J. S. Gill²
Establishing a New Hepatobiliary Surgery Program in a Level 1 Trauma Center Community Teaching Hospital (Our Open and Robotic Experience)

J. S. Han, S. A. Neubauer, C. E. Renner, C. M. Dunham, T. J. Chirichella
Establishment And Validation Of A Predictive Model For Differential Rejection Diagnosis By Gene Expression Profiling (GEP) In Renal Allograft Biopsies Using Banff Human Organ Transplant (B-HOT) Gene Panel

H. Zhang¹, R. Haun², F. Collin¹, C. Cassol², S. Coley², J. Wilson², S. Stone¹, K. Qu¹, W. Tian¹, N. Agrawal¹, G. Shekhtman¹, C. Larsen²
Establishment of an In Vitro Assay to Evaluate Indirect T-cell Allo-Response Using Donor PBMC-Pulsed Dendritic Cells

K. Iwasaki¹, T. Tomosugi², T. Sekiya³, H. Hamana⁴, Y. Miwa¹, K. Futamura², M. Okada², T. Hiramitsu², N. Goto², S. Narumi², Y. Watarai², H. Kishi⁴, M. Okumura⁵, S. Ashimine⁵, K. Ishiyama⁵, T. Kobayashi⁵
Estimating the Effect of Increased Donor Heart Ischemic Time on Post-Transplant Survival Using Instrumental Variables

G. Ran¹, K. Lazenby¹, N. Narang², W. F. Parker³
Estrogen Receptor Beta Deletion is Protective in Renal Ischemia Reperfusion Injury but Pharmacologic Inhibition of Estrogen Receptor Beta is Not

C. OBrien¹, P. Hernandez², S. Concors², Z. Wang¹, G. Ge¹, W. Hancock³, M. Levine²
Ethnic Variation in Adult and Pediatric Liver Transplantation

N. Kemmer¹, M. Malespin¹, S. Agrawal¹, R. Syed¹, K. Alkhalloufi¹, B. Alkurdi¹, C. Albers¹, J. Buggs²
Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study

P. West-Thielke, W. Ally, J. Hickey, L. Stach, J. Fleming, T. Cober, A. Kawano, I. Agboli, C. Miller, J. Holman
Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study

T. Ivanics¹, D. So², M. P. Claasen³, D. Wallace⁴, M. Patel⁵, A. Gravely⁶, K. Walker⁷, T. Cowling⁷, L. Erdman⁸, G. Sapisochin³
Evaluating the Risk and Benefit of Once Daily Delayed Release Mycophenolate in Pediatric Kidney Transplant Recipients

L. Maestretti¹, A. McGrath¹, A. Fong¹, A. Brubaker², A. Gallo³, P. Grimm³, A. Chaudhuri³
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients

M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
Evaluation of Compliance and Efficacy with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Tacrolimus in Kidney Transplant Recipients

M. Nikirk¹, J. Chen¹, E. Tillman²
Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients

E. Foster¹, A. Iaria¹, J. Negrelli², M. Fine², M. Yu², M. Liebo²
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients

R. Gordon¹, K. Dewey¹, R. Jariwala¹, B. Yen¹, J. Kukreja², S. Hays², J. Singer², R. Florez¹
Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study

C. Killian¹, R. Reed¹, M. McLeod¹, P. MacLennan¹, V. Kumar¹, S. Brooks¹, A. Maynor¹, L. Stanford¹, G. Baker¹, C. Schinstock², J. Silkensen³, G. Roll⁴, D. Segev⁵, B. Orandi¹, C. Lewis¹, J. Locke¹
Evaluation of Different Initial Tacrolimus Dosing Regimens in Pediatric Post-Liver Transplantation

A. F. Alghanem¹, A. Alsmari¹, H. Joharji²
Evaluation of Donor Exclusion Criteria in Living Donor Liver Transplantation: A Single-Center Experience

D. Daskalaki, M. E. Akoad, J. Kim, C. J. Simon, Y. Cheah
Evaluation of Genotype Based Clustering Method of Single-Cell RNA-Sequencing Data from Human Kidney Allograft Biopsies

G. Thareja¹, A. Belkadi¹, S. Rahim², H. Yang², F. B. Mueller², K. Suhre¹, M. Suthanthiran², T. Muthukumar²
Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population

S. E. Lawrence, M. R. Norvell, K. Schwarz, B. Crowther, P. Klem
Evaluation of Hepatitis C Positive Donor to Hepatitis C Negative Recipient Kidney Transplant in a Highly Sensitized Patient Population

A. T. Iaria, M. Martin, A. Hietpas, I. Tang, S. Koppe, I. Tzvetanov, E. Benedetti, C. Muran
Evaluation of Post-Transplant Angiotensin II Type 1 Receptor Antibodies, Donor-Derived Cell-Free DNA, and Rejection in Heart Transplant Recipients

B. Agegnehu¹, S. Sterling¹, R. Winstead¹, I. Tchoukina²
Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution

E. Foster¹, D. Pierce¹, T. Cairns¹, S. Borgetti², I. Tzvetanov³, E. Benedetti³, C. Muran¹
Evaluation of Renal Function After Donation in Living Marginal Kidney Donor

S. Harada¹, H. Sasaki², Y. Takada², D. Takamoto², T. Hirano², T. Kan¹, Y. Yamagata¹, H. Harada², K. Minami¹, K. Moriya¹, H. Tanaka¹
Evaluation of Technical Bladder Complications in Kidney Transplantation Recipients with a Prolonged Dialysis History

S. M. Zielsdorf, K. Kushwaha, C. Goldbeck, S. Martin, Y. Kwon, K. Etesami, J. Kim, J. Emamaullee, S. Zielsdorf
Evaluation of the Management of Cytomegalovirus in Kidney Transplant Recipients After Establishment of a Multidisciplinary Cytomegalovirus Workgroup

A. Boyle, A. Spenningsby, H. Rhodes, T. Anderson-Haag
Evaluation of the Significance of Isolated C4d Staining without Histological Evidence of Rejection on Kidney Biopsies After ABO-Compatible Transplantation in Pediatric Recipients

C. Duneton¹, M. Rabant², J. Duong-Van-Huyen², V. Baudouin¹, E. Cheyssac¹, O. Boyer³, J. Hogan¹
Evaluation of UW-Based Solutions Formulated to Be Anti-Apoptotic and Neuroprotective of Retinal Ganglion Cells (RGCs) Following Whole Eye Transplantation (WET) in a Rat Model

N. J. Khatter¹, Y. Wang¹, B. Li¹, C. R. Owens¹, A. H. Jani², C. A. Huang¹, R. W. Nickells³, A. A. Su¹, K. M. Washington¹
Evaluation of Voriconazole Dosing for Preventing Aspergillus in Lung Transplant Recipients

A. Chaplain¹, B. J. Pierce¹, C. Pham¹, A. Hutchins¹, W. L. Musick¹, D. T. Nguyen², E. A. Graviss², S. W. Yau³, J. G. Youssef³, A. Goodarzi³, H. J. Huang³
Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial to Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing iκB-α

Z. Gui¹, W. Zijie², M. Zheng³, M. Gu¹, R. Tan³
Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor

J. M. Vanatta¹, R. A. Helmick², C. Eymard², N. Nezakatgoo², P. Horton², J. P. Kothadia², S. P. Nair², J. D. Eason²
Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial

B. Hagerf¹, Z. Hladíková¹, M. Zahradnická¹, K. Kesslerová², T. Sosna², P. Girman¹, F. Saudek¹
Evidence for Improved Quality of Life Among Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Autotransplantation Using EORTC QLQ-C30 and QLQ-PAN 26

M. Coluzzi, B. Naziruddin, G. Saracino, G. Testa, E. Beecherl, N. Onaca
Evolution of Cellular and Humoral Immunity During and After a Three Doses-Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients

D. Cucchiari¹, N. Egri¹, J. Casals-Urquiza², J. Del Risco-Zevallos¹, D. Rodríguez-Espinosa³, E. Montagud-Marrahi², J. Rovira⁴, M. Ramirez-Bajo⁵, E. Banón-Maneus⁵, P. Ventura-Aguiar², M. Pascal¹, I. Revuelta⁶, B. Bayès², F. Diekmann²
Evolution of Donation After Circulatory Death Liver Transplantation in the United States

M. Finotti, G. McKenna, J. Bayer, H. Fernandez, S. Lee, E. Martinez, N. Onaca, G. Saracino, R. Ruiz, G. Testa, A. Gupta, A. Wall
Evolution of Donor-Derived Cell-Free DNA During the First Week After Surgery Predicts Renal Function Recovery After Kidney Transplantation

D. Cucchiari¹, E. Cuadrado¹, E. Gonzalez¹, J. Puig¹, M. Ramirez-Bajo¹, P. Ventura-Aguiar¹, I. Revuelta², B. Bayès¹, F. Diekmann¹
Evolution of Pretransplant Cardiac Risk Factor Burden and Major Adverse Cardiovascular Events in Liver Transplant Recipients Over Time

C. Harrington, P. Levy, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner
Evolution of the Need for Transplant Evaluations for Liver Failure Decompensation After TIPS

N. Kemmer¹, V. Sureshkumar², L. Grater³, G. Hoots⁴, S. Agrawal¹, K. Robichaux⁵, M. Gosselin³, S. Mohammed⁵, A. Kumar⁶, J. Buggs⁷
Evolving Trends In The Management And Outcome Of Duodenal Complications After Pancreas Transplantation: A 20-year Single Institution Experience

S. Ray¹, C. Parmentier¹, G. Sapisochin¹, A. Yousuf¹, I. McGilvray¹, A. Norgate¹, M. Cattral¹, M. Selzner², T. Reichman³
Evs from Patients with Amr Induce Tubular Senescence and Endmt Through Horizontal Transfer of Mirnas

R. Franzin¹, A. Stasi¹, F. Sallustio¹, S. Bruno², G. Merlotti³, M. Quaglia³, G. Grandaliano⁴, P. Pontrelli¹, J. Thurman⁵, G. Camussi², G. Stallone⁶, V. Cantaluppi³, L. Gesualdo¹, G. Castellano⁷
Ex Vivo End Ischemic Hypothermic Oxygenated Perfusion (hope) Versus Static Cold Storage Prior To Liver Transplantation – Preliminary Results Of The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The Vitasmart Liver Machine Perfusion System (clinicaltrials.gov: Nct05045794)

D. J. Reich¹, A. Schlegel², M. Rizzari³, D. Foley⁴, M. DeVera⁵, W. Chapman⁶, G. Roll⁷, A. Saharia⁸, C. Quintini⁹, S. Florman¹⁰, S. Merani¹¹, S. Mao¹², A. Pinna¹³, M. Akoad¹⁴, C. Kubal¹⁵, S. Alexopoulos¹⁶, H. Bohorquez¹⁷
Ex Vivo Liver Resection and Autotransplantation – Should It Be Used More Frequently?

J. Weiner¹, A. Griesemer¹, A. Hemming², D. Levi³, T. Beduschi⁴, R. Matsumoto¹, A. Mathur¹, J. Emond¹, T. Kato¹
Ex Vivo Modification of Vascular Allografts Using Immunosuppressive and Anti-Inflammatory Polymers Prevent Rejection via Localized Immunosuppression

H. D. Luo¹, E. M. Siren¹, W. Enns², L. Sim¹, C. Du¹, S. G. Withers¹, J. Choy³, J. N. Kizhakkedathu¹
Exacerbation of Racial Disparities in Living Donor Kidney Transplant During the Covid-19 Pandemic

N. Singh¹, R. Li², T. Alhamad³, M. A. Schnitzler⁴, R. B. Mannon⁵, M. D. Doshi⁶, K. J. Woodside⁶, B. E. Hippen⁷, M. Cooper⁸, J. Snyder⁹, D. A. Axelrod¹⁰, K. L. Lentine⁴
Excellent Long-Term Outcome of ABO-Incompatible Living Kidney Transplantation by Reduced-Session of Plasmapheresis of Desensitization Protocol

Y. Ishiyama¹, K. Tanabe², T. Kanzawa², K. Unagami², H. Ishida², T. Takagi²
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young
Exosomal TGFbeta:LAP as Immunosuppressive Mediator of Allo-Tolerance

W. Burlingham¹, E. Jankowska-Gan², J. Fechner³, C. Little², J. Sullivan⁴, D. Foley¹
Expanded Criteria Donor with Severe Acute Kidney Injury: Worth to Use?

S. Thotsiri, N. Sutharattanapong, C. Janphram, P. Wiwattanathum
Expanded Experience with Ultra-Short Duration Pangenotypic Direct Acting Anti-Viral (DAA) Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients (KT)

I. Yakubu, D. Kumar, A. Sharma, M. Levy, L. Kamal, G. Gupta
Expanding Access to Robotic Kidney Transplantation for Candidates with High BMI. A Training Tool for Transplant Centers

J. A. Almario Alvarez, G. Aguiluz, V. Valle, R. Bustos, S. Akshelyan, A. M. Fratti, P. D. Cocco, M. Spaggiari, I. G. Tzvetanov, E. Benedetti
Experience of Over 5 Years and Over 400 Cases of Pure Laparoscopic Donor Right Hepatectomy

K. Suh, S. Hong, S. Lee, S. Suh, S. Hong, E. Han, Y. Choi, N. Yi, K. Lee
Experience Using Intra-Operative Dialysis in Surgically Complex Liver Transplantation

M. Palascak¹, D. Arango¹, S. Yockelson¹, J. Koveleskie¹, D. Ganier¹, A. Cohen², H. Bohorquez²
Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients

M. Gibson¹, D. Belshe¹, G. Gregory¹, S. Tanna¹, M. Ison¹, S. Ildstad², J. R. Leventhal¹
Experience with the First Two Living Donor Robotic Left Lobe Hepatectomies in the USA

M. E. Tobon Lascano, M. Akoad, C. Simon, J. Kim, Y. Cheah
Exploration of the Optimal pH in Hypothermic Machine Perfusion for Rat Liver Grafts Retrieved from Circulatory Death

S. Sakamoto¹, M. Fukai¹, K. Shibata¹, H. Bochimoto², N. Mohd Zin², N. Kawamura¹, T. Ishikawa¹, M. Fujiyoshi¹, T. Shimamura³, A. Taketomi¹
Exploring Individual Optimal Immunosuppression Management According to the Oncological Risk in Liver Transplanted Patients with Hepatocellular Carcinoma

K. Sasakik¹, S. Kimura², D. Soma³, K. Tomiyama⁴, M. Matthew⁴, M. Fruscione², C. Kubal³, D. Kwon⁵
Exploring the Differential Access Hypothesis: Do Black Kidney Transplant Candidates Have Less Social Network Access to Potential Living Donors Than White Candidates?

J. Daw¹, M. Roberts¹, T. Purnell²
Extended Duration of Rabbit Antithymocyte Globulin (rATG) Induction in Kidney and Kidney/Pancreas Transplant Recipients

D. Majmundar, A. Di Carlo, A. Diamond
External Validation of the Abbreviated Ibox Scoring System at One-Year Post Kidney Transplant as a Surrogate Endpoint for Death-Censored Graft Survival

A. Klein¹, L. Kosinski², R. Muse², A. Loupy³, O. Aubert³, G. Divard³, M. Stegall⁴, I. Helanterä⁵, W. E. Fitzsimmons¹, I. O'Doherty¹